The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Open accessAbstract
BACKGROUND & AIMS: The prevalence of chronic hepatitis C (CH-C) remains high and the complications of infection are common. Our goal was to project the future prevalence of CH-C and its complications. METHODS: We developed a multicohort natural history model to overcome limitations of previous models for predicting disease outcomes and benefits of therapy. RESULTS: Prevalence of CH-C peaked in 2001 at 3.6 million. Fibrosis progression was inversely related to age at infection, so cirrhosis and its complications were most common after the age of 60 years, regardless of when infection occurred. The proportion of CH-C with cirrhosis is projected to reach 25% in 2010 and 45% in 2030, although the total number with cirrhosis will peak at 1.0 million (30.5% higher than the current level) in 2020 and then decline. Hepatic decompensation and liver cancer will continue to increase for another 10 to 13 years. Treatment of all infected patients in 2010 could reduce risk of cirrhosis, decompensation, cancer, and liver-related deaths by 16%, 42%, 31%, and 36% by 2020, given current response rates to antiviral therapy. CONCLUSIONS: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age. Current treatment patterns will have little effect on these complications, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Self-citationRising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Self-citationThe Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Self-citationAltekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Self-citationClinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Self-citationRates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Self-citationInsulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 710
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Sangiovanni, A., Prati, G. M., Fasani, P., Ronchi, G., Romeo, R., Manini, M., Del Ninno, E., Morabito, A., & Colombo, M. (2006) · Hepatology · doi:10.1002/hep.21176 · Cited by 628
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Self-citationBruno, S., Stroffolini, T., Colombo, M., Bollani, S., Benvegnù, L., Mazzella, G., Ascione, A., Santantonio, T., Piccinino, F., Andreone, P., et al. (2007) · Hepatology · doi:10.1002/hep.21492 · Cited by 604
Veldt, B. J., Heathcote, E. J., Wedemeyer, H., Reichen, J., Hofmann, W. P., Zeuzem, S., Manns, M. P., Hansen, B. E., Schalm, S. W., & Janssen, H. L. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-10-200711200-00003 · Cited by 602
Projecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 576
Self-citationEstimating future hepatitis C morbidity, mortality, and costs in the United States
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 567
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Self-citationDavila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Self-citationHepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
Degos, F., Christidis, C., Ganne-Carrie, N., Farmachidi, J.-P., Degott, C., Guettier, C., Trinchet, J.-C., Beaugrand, M., & Chevret, S. (2000) · Gut · doi:10.1136/gut.47.1.131 · Cited by 370
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies
Pawlotsky, J., Chevaliez, S., & McHutchison, J. G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.116 · Cited by 325
Epidemiology of hepatocellular carcinoma in USA
El‐Serag, H. B. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00168.x · Cited by 320
Self-citationHepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
Self-citationRyder, S. D. (2004) · Gut · doi:10.1136/gut.2003.021691 · Cited by 276
Changing trends in hepatitis C–related mortality in the United States, 1995‐2004†‡
Wise, M., Bialek, S., Finelli, L., Bell, B. P., & Sorvillo, F. (2008) · Hepatology · doi:10.1002/hep.22165 · Cited by 229
Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors
Missiha, S. B., Ostrowski, M., & Heathcote, E. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.069 · Cited by 228
Modeling the Hepatitis C Virus Epidemic in France
Deuffic, S., Buffat, L., Poynard, T., & Valleron, A.-J. (1999) · Hepatology · doi:10.1002/hep.510290528 · Cited by 210
Self-citationHepatitis C Virus–Associated Fulminant Hepatic Failure
Farci, P., Alter, H. J., Shimoda, A., Govindarajan, S., Cheung, L. C., Melpolder, J. C., Sacher, R. A., Shih, J. W., & Purcell, R. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350904 · Cited by 189
Barriers to the treatment of hepatitis C: Patient, provider, and system factors
Morrill, J. A., Shrestha, M., & Grant, R. W. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0161.x · Cited by 180
Chronic liver disease mortality in the United States, 1990-1998
Vong, S., & Bell, B. P. (2004) · Hepatology · doi:10.1002/hep.20049 · Cited by 159
Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors
Guiltinan, A. M., Kaidarova, Z., Custer, B., Orland, J., Strollo, A. M., Cyrus, S., Busch, M. P., & Murphy, E. L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm370 · Cited by 133
Wright, M., Goldin, R. D., Fabre, A., Lloyd, J., Thomas, H. C., TREPO, C. G., Pradat, P., & Thursz, M. R. (2003) · Gut · doi:10.1136/gut.52.4.574 · Cited by 132
Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?
Thabut, D., Calvez, S. L., Thibault, V., Massard, J., Munteanu, M., Martino, V. D., Ratziu, V., & Poynard, T. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00556.x · Cited by 117
Self-citationOutcome of Hospital Care of Liver Disease Associated With Hepatitis C in the United States
Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, R. G., & Dickson, R. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20798 · Cited by 106
Neal, K. R., & on behalf of the Trent Hepatitis C Study Group (2007) · Gut · doi:10.1136/gut.2006.113217 · Cited by 102
Progression to cirrhosis in hepatitis C patients: an age‐dependent process
Pradat, P., Voirin, N., Tillmann, H. L., Chevallier, M., & TREPO, C. G. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01430.x · Cited by 99
Franchini, M., Rossetti, G. M., Tagliaferri, A., Capra, F., Maria, E. D., Pattacini, C., Lippi, G., Cascio, G. L., Gironcoli, M. D., & Gandini, G. (2001) · Blood · doi:10.1182/blood.v98.6.1836 · Cited by 96
Limitations of conventionally derived chronic liver disease mortality rates
Manos, M. M., Leyden, W. A., Murphy, R. C., Terrault, N. A., & Bell, B. P. (2008) · Hepatology · doi:10.1002/hep.22181 · Cited by 96
Predicting progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Law, M. G., Kaldor, J. M., & Dore, G. J. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00436.x · Cited by 95
Rate of natural disease progression in patients with chronic hepatitis C
Zarski, J., Hutchison, J. M., Zarski, J., Stürm, N., Garcia‐Kennedy, R., Hodaj, E., Truta, B., Wright, T. L., & Gish, R. G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00387-2 · Cited by 81
Datz, C., Cramp, M., Haas, T., Dietze, O., Nitschko, H., Froesner, G., Muss, N., Sandhofer, F., & Vogel, W. (1999) · Gut · doi:10.1136/gut.44.4.563 · Cited by 79
Persistence of Viremia in Patients with Type-C Chronic Hepatitis during Long-Term Follow-up
Yousuf, M., Nakano, Y., Tanaka, E., Sodeyama, T., & Kiyosawa, K. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011189 · Cited by 64
Clinical pathways for patients with newly diagnosed hepatitis C – What actually happens
Irving, W. L., Smith, S., Cater, R. E., Pugh, S., Neal, K. R., Coupland, C. A. C., Ryder, S. D., Thomson, B. J., Pringle, M., Bicknell, M., et al. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00698.x · Cited by 63
Improving the accuracy of long‐term prognostic estimates in hepatitis C virus infection
Yi, Q., Wang, P., & Krahn, M. D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00484.x · Cited by 52
Levine, R. A., Sanderson, S. O., Ploutz-Snyder, R. J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.028 · Cited by 49
Ferenci, P., Ferenci, S., Datz, C., Rezman, I., Oberaigner, W., & Strauß, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.023 · Cited by 47
Prevalence of Hepatitis C–Related Cirrhosis in Elderly Asian Patients Infected in Childhood
D'Souza, R., Glynn, M. J., Ushiro‐Lumb, I., Feakins, R. M., Domizio, P., Mears, L., ALSCED, E., KUMAR, P., Sabin, C. A., & Foster, G. R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00527-6 · Cited by 43
Russmann, S., Dowlatshahi, E. A., Printzen, G., Habicht, S., Reichen, J., & Zimmermann, H. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-5 · Cited by 42
Hepatitis C in the Elderly: Epidemiology, Natural History, and Treatment
Mindikoglu, A. L., & Miller, R. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.07.017 · Cited by 38
Sersté, T., & Bourgeois, N. (2007) · PubMed · Cited by 37
The impact of competing risks on the observed rate of chronic hepatitis C progression
Kim, W. R., Poterucha, J. J., Benson, J. T., & Therneau, T. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.052 · Cited by 30
Cited by
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Self-citationEpidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Self-citationEpidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2021) · Hepatology · doi:10.1002/hep.31288 · Cited by 2,147
Self-citationGlobal epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Metadata
- Authors
- Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 138
- Issue
- 2
- Pages
- 513-521.e6
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2042158802
- Cited by
- 878
- References
- 58
- FWCI
- 35.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.